Physician profile
Alexandre Benjo
NPI 1164606448
$15,387.77
in general payments reported to CMS, 2019-2025
39 companies · $2,382 in 2025
The $2,382 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,402 · 2020: $1,143 · 2021: $2,105 · 2022: $2,695 · 2023: $1,400 · 2024: $3,262 · 2025: $2,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,983 · Travel and Lodging: $60.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,982.80 |
| Travel and Lodging | $60.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,577.91 | 2019-2025 | Cardiomems, Aveir, Emboshield Nav6 |
| Cvrx, INC. | $1,840.10 | 2022-2025 | Barostim Neo System |
| Medtronic, INC. | $1,678.35 | 2021-2025 | Venaseal, Micra, Evera Mri Xt Dr Surescan |
| Medtronic Vascular, INC. | $1,286.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $1,203.50 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $972.13 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $624.15 | 2022-2025 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $411.26 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $396.98 | 2024-2025 | Assure Wcd |
| Abiomed | $394.62 | 2020-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $369.02 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $345.10 | 2021-2025 | Winrevair, Verquvo |
| Biotronik INC. | $316.72 | 2019-2020 | |
| Edwards Lifesciences Corporation | $315.77 | 2024-2025 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $173.55 | 2020-2025 | Opsumit, Uptravi |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $148.59 | 2024-2025 | Carto 3 |
| Elutia, INC. | $137.40 | 2025 | Ecm Patch,Pouch |
| Cardiva Medical, INC. | $124.54 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Angiodynamics, INC. | $112.45 | 2025 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $111.32 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $88.38 | 2019-2023 | Farxiga |
| Boston Scientific Corporation | $81.36 | 2019-2025 | Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $81.04 | 2021 | |
| Amarin Pharma, INC. | $69.75 | 2020-2021 | |
| Inari Medical, INC. | $68.27 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lundbeck LLC | $65.79 | 2019-2020 | |
| Amgen INC. | $61.20 | 2020-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.07 | 2022-2023 | Jardiance |
| Cardiovascular Systems INC. | $52.00 | 2020-2021 | |
| Novo Nordisk INC | $38.52 | 2023 | Ozempic |
| Chiesi USA, INC. | $36.73 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $24.26 | 2024 | Arcalyst |
| Atricure, INC. | $23.92 | 2022 | |
| Vital Connect, INC | $22.14 | 2023 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $19.44 | 2024 | |
| Itamar Medical INC | $18.02 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $17.96 | 2023 | Arcalyst |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Benjo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.